Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

MAP 2015 – Molecular Analysis for Personalised Therapy

MAP 2015 – Molecular Analysis for Personalised Therapy
Start date
23 Oct 2015
End date
24 Oct 2015
Location
Paris, France

We are pleased to announce the first Molecular Analysis for Personalised therapy (MAP) meeting – a joint initiative from UNICANCER, ESMO and Cancer Research UK.

This new conference explored the clinical interpretation of molecular tests for metastatic cancers, where the development of new biotechnologies has revolutionised the applications of personalised therapy. This emerging topic was discussed in detail and offered oncologists practical solutions for clinical treatment.

Full details of this new conference can be found on the dedicated MAP 2015 website.

 View the MAP 2015 scientific programme

Press Release

MAP 2015 Press Release: Genomic Alterations could lead to a brave new world for cancer treatment

Programme

The MAP conference equipped clinicians and researchers with the information to interpret clearly the molecular analyses of their patients. Scientific presentations by international leaders highlighted the latest advances in the field of personalised medicine for cancer patients.

Genomic clinical cases offered real-life examples of clinical interpretation in this field of genetic science, while roundtable discussions allowed participants to exchange on how to prioritise targets in cancer patients.

The full programme can be viewed on the MAP 2015 website.

Venue

Maison de la Chimie
28 rue Saint-Dominique
75007 Paris

Founders & Committees

Founders
  • Jean-Charles Soria, Gustave Roussy, Villejuif, FR
  • Charles Swanton, London Research Institute, UK
  • Fabrice André, Gustave Roussy, Villejuif, FR
Organising committee
  • Fédération UNICANCER: Pascale Flamant, Déléguée générale
  • Cancer Research UK: Ian Walker, CEO
  • ESMO: Alessia Mora, Head of Congress Department
Local host committee
  • Christophe Jamain, Direction scientifique R&D UNICANCER
  • Agathe Lasne, Chargée de communication, UNICANCER
  • Overcome agency

Organisation & registration

Overcome
3-5 Boulevard Paul-Emile Victor
92523 Neuilly sur Seine cedex - France
Tel: +33 (0)1 41 92 01 27
Fax: +33 (0)1 40 88 97 90
E-mail: map@overcome.eu

Accommodation

Reservations will be processed in order of receipt of applications and depending on availability. For information, please contact the MAP housing team:
Tel: +33 (0)1 40 88 97 97
E-mail: map@overcome.eu

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings